Massmedica S.A. (WSE:MSM)

Market Cap	10.14M -11.4%
Revenue (ttm)	28.97M -11.9%
Net Income	676.13K -22.8%
EPS	0.28 -22.8%
Shares Out	2.41M
PE Ratio	15.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Open	4.240
Previous Close	4.130
Day's Range	4.200 - 4.240
52-Week Range	3.260 - 7.500
Beta	0.36
Analysts	n/a
Price Target	n/a
Earnings Date	May 15, 2026

About Massmedica

Massmedica S.A. engages in the distribution of implants and other medical materials used in the treatment of musculoskeletal system diseases, aesthetic and regenerative medicines in Poland. It offers products in the field of reconstructive, regenerative, anti-aging, and aesthetic medicine. The company’s products include dietary supplements, skin care cosmetics, sun protection creams, tools, serum, masks, carboxytheraphy, and intra-articular injections for regeneration of the knee joints. It also provides reconstructive products, such as hip end...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 2011
• Employees: 15
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: MSM

Financial Performance

In 2024, Massmedica's revenue was 32.62 million, an increase of 23.71% compared to the previous year's 26.37 million. Earnings were 814,684, an increase of 59.11%.